Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

67.59
Delayed Data
As of Dec 08
 -1.03 / -1.50%
Today’s Change
66.93
Today|||52-Week Range
88.49
-21.44%
Year-to-Date
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Dec 07 / Zacks.com - Paid Partner Content
Stock Futures Rise as Wall Street Shrugs Off Italy Referendum Defeat; Oil Gains
Dec 05 / TheStreet.com - Paid Partner Content
Teva Copaxone EU Label to Omit Pregnancy Contraindication
Dec 07 / Zacks.com - Paid Partner Content
Patient Deaths, Safety Concerns Cause Juno's CAR-T Pipeline to Skid Out
Dec 05 / TheStreet.com - Paid Partner Content
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Dec 07 / MotleyFool.com - Paid Partner Content
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.
Nov 30 / Zacks.com - Paid Partner Content
Robust Pipeline Supports 5.5% Dividend Yield
Dec 05 / GuruFocus News - Paid Partner Content
Johnson & Johnson Throws Caution to the Wind With a Large Bid for Actelion
Nov 30 / MotleyFool.com - Paid Partner Content
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data
Dec 05 / Zacks.com - Paid Partner Content